Epigenomics raises EUR 41.6M in IPO

Molecular diagnostics company Epigenomics (FSE:ECX) raised EUR 41.6 million ($51.5 million) in an IPO through the sale of about 4.6 million shares at EUR 9, giving it a post-money valuation of about EUR 143 million ($177 million).The deal, which has a 693,000 share overallotment, was underwritten by Morgan Stanley; Lehman Brothers; and DZ Bank. ...